Live Breaking News & Updates on Refractory Acute Lymphoblastic Leukemia

Stay updated with breaking news from Refractory acute lymphoblastic leukemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investigational Allo-HSCT for Advanced Hematologic Malignancies

The expert panel shares emerging data on an engineered, allogeneic cell-based therapy administered as part of conditioning for allo-HSCT in patients with relapsed, refractory, or high-risk hematologic cancers. ....

Optimizing Outcomes , Allogeneic Transplants , Advanced Hematologic , Hematologic Malignancies , Hematologic Cancers , Allo Hsct , Allogeneic Transplant , Allo Transplant , High Risk , Advanced Hematologic Malignancies , Investigational Allo Hsct ,

Calderys Group reports successful integration of HWI and Calderys

Calderys Group reports successful integration of HWI and Calderys ....

Michel Cornelissen , Calderys Group , Middle East ,

In Refractory IBD, Combination Tx Appears Safe, Effective

In the treatment of IBD, combinations of biologics or a biologic and tofacitinib appeared to be generally safe and effective, according to a new systematic review and meta-analysis. ....

United States , Davidt Rubin , Ali Osman , Crohn Colitis Foundation , Pcrohn Colitis Congress , Washington University School Of Medicine , American Gastroenterological Association , Colitis Foundation , American Gastroenterological , Washington University School , Inflammatory Bowel Disease Center , Inflammatory Bowel Disease Ibd , Biologic Therapy , Meta Analysis , Adverse Effects , Side Effects , Crohn Amp 039s Disease , Crohn Disease , Egional Enteritis Crohn S , Patient Safety , Ulcerative Colitis , Lcerative Colitis Uc , C Ulcerative Colitis , Targeted Therapy , Targeted Cancer Therapy ,

Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

The phase 3 study findings supported belantamab mafodotin as a potential new standard of care in the second line or later among patients with released/refractory multiple myeloma. ....

Castillay Leóp , Maria Victoria Mateos , University Hospital Of Salamanca , University Hospital , Multiple Myeloma , Plasma Cell Myeloma , Proteasome Inhibitor , Biologic Therapy , Anemia Anaemia , Monoclonal Antibody ,

Rosacea and Recent Research Back Potential New Therapies

What do botulinum toxin, paroxetine, and a low-molecular-weight heparan sulfate analog have in common? Each has evidence as a potential treatment for people with rosacea. ....

United States , University Of South Florida , Susan Weinkle , Diane Thiboutot , National Rosacea Society Expert Committee , Journal Of The American Academy Dermatology , Penn State College , American Academy , South Florida , Sulfate Analog , Growing Case , National Rosacea Society Expert , Acne Rosacea , Skin Lesion , Botulinum Toxin , Botox Injection , Antidepressant Drug , Social Phobia , Social Anxiety , C Reactive Protein , Laser Therapy , Hobic Disorder ,